Skip to main content
Caplight Logo









Nurture Genomics

Nurture Genomics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://nurturegenomics.com/

Last Round

VC Round

Sep 9, 2025

Total Funding Raised

$3.41M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nurture Genomics is a healthcare services company that provides genetic testing services intended for newborns and children.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Biotechnology, Patient Engagement

Business Model

B2C

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

whole genome sequencingWGSpediatric genomic screeninggenetic counselingnewborn screeningprecision medicinetelemedicinedirect-to-consumer genomicsDTC genetic testinggenomic health insightsdigital healthpediatric caregenetic testingDNA screeningpreventative genomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nurture Genomics Comparables

Compare Nurture Genomics with similar companies based on industry and business-model similarity.

Nurture Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LetsGetChecked
83%
Fulgent Genetics, Inc.
76%
Rady Children's Institute for Genomic Medicine
76%

Nurture Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 9, 2025
SAFEAug 8, 2023
Early FundingApr 20, 2023

Nurture Genomics Investors

Notable investors and investment history

Nurture Genomics investors
InvestorRounds
HealthTech CapitalSAFE, VC Round, Early Funding
Bantam GroupSAFE, VC Round
The Charles Hood FoundationSAFE
ImpactAssetsSAFE, VC Round, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 165% MoM.

  • Jun 20, 2026

    Monthly visitors increased 1257% MoM, from 49 to 665.

Nurture Genomics Filings

Explore SEC and related filing metadata, where available.

Nurture Genomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nurture Genomics's valuation, stock price, and market status.

Is Nurture Genomics a public or private company?

Nurture Genomics is a private company.

What is the current stock price of Nurture Genomics?

Nurture Genomics is a private company, so its shares have no public market price. Caplight tracks Nurture Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nurture Genomics worth (valuation)?

Valuation information for Nurture Genomics is not publicly available.

Can I buy Nurture Genomics stock?

Nurture Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nurture Genomics's last funding round?

Nurture Genomics's most recent funding round was VC Round on September 9, 2025.

Who are the main investors in Nurture Genomics?

Key investors in Nurture Genomics include ImpactAssets.

Will Nurture Genomics IPO soon?

No public IPO plans have been announced for Nurture Genomics.

How can I track Nurture Genomics secondary market activity?

Caplight tracks bids, offers, and trades in Nurture Genomics's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range15
Year Founded2022
Last FundingSep 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?